Why the study?
Does a conventional ICD externally connected to a transvenous lead provide safe and efficacious bridging therapy in patients explanted for ICD infections?
Does a conventional ICD externally connected to a transvenous lead provide safe and efficacious bridging therapy in patients explanted for ICD infections?
Using a conventional ICD externally connected to a transvenous lead is a safe and effective bridging strategy for patients requiring prolonged antibiotic therapy after ICD explantation for infection.
Answers are grounded in this paper and cite their sources.
May support external ICD bridging post-explant; hypothesis-generating and requires prospective validation before wider use.
BACKGROUND: The management of patients explanted for implantable converter defibrillator (ICD) infections may be complex when anti-bradycardia pacing and tachyarrhythmia protection are needed. We aimed to test the efficacy and safety of a conventional ICD externally connected to a transvenous dual-coil lead as bridging therapy before the reimplantation. METHODS AND RESULTS: We enrolled seven patients explanted for ICD infections and needed prolonged antibiotic therapy in two high-volume hospitals in Italy and treated them with a passive-can external ICD for a mean of 13 (4-30) days before reimplant. One patient experienced an electrical storm, efficaciously recognized by the external ICD and treated with antitachycardia pacing and shocks. On-demand pacing was granted for all the patients. No device-related complications were reported. CONCLUSIONS: An external ICD seems safe and efficacious as a bridge to reimplant in patients explanted for ICD infections.
No takes yet. Share an insight, caveat, or question.
Dell’Era et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: